CAS: 134523-00-5 - Atorvastatin

Fórmula: C₃₃H₃₅FN₂O₅

InChI: InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1

Clave InChI: InChIKey=XUKUURHRXDUEBC-KAYWLYCHSA-N

SMILES: O=C(O)CC(O)CC(O)CCN1C(C=2C=CC(F)=CC2)=C(C=3C=CC=CC3)C(C(=O)NC=4C=CC=CC4)=C1C(C)C

Sinónimos:

• (3R,5R)-7-[2-(4-Fluorophenyl)-3-Phenyl-4-(Phenylcarbamoyl)-5-Propan-2-Yl-Pyrrol-1-Yl]-3,5-Dihydroxy-Heptanoic Acid
• (3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
• (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
• (3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
• (3S,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
• (βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
• (βR,δR)-2-(p-Fluorophenyl)-β,δ-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid
• 1H-Pyrrole-1-Heptanoic Acid
• 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δR)-
• 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δR)-rel-
• 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, [R-(R*,R*)]-
• 1H-pyrrole-1-heptanoate, 3-benzoyl-5-(4-fluorophenyl)-β,δ-dihydroxy-2-(1-methylethyl)-4-phenyl-, calcium salt, (betaR,deltaR)- (1:1)
• Atavastatin
• Atofast
• Atorcor
• Atorfit 20
• Atorin
• Atoris
• Atorvastatin Acid
• Atorvox
• Atrox
• Cardyl
• Lipilou
• Lipinon
• Statofilm
• calcium bis{(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate}
• Atorvastatin

Atorvastatin Calcium Salt Trihydrate

CAS: 134523-00-5134523-03-8 344423-98-9

• Fórmula: C₆₆H₆₈CaF₂N₄O₁₀·3H₂O
• Pureza: >98.0%(HPLC)(N)
• Forma y color: White to Almost white powder to crystal
• Peso molecular: 1,209.41

(3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid

CAS: 134523-00-5

• Fórmula: C₃₃H₃₅FN₂O₅
• Pureza: 98%
• Forma y color: Solid
• Peso molecular: 558.6398

Atorvastatin

CAS: 134523-00-5

• Fórmula: C₃₃H₃₅FN₂O₅
• Pureza: ≥ 98.5%
• Forma y color: White to off-white crystalline powder
• Peso molecular: 558.64

(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid

CAS: 134523-00-5

• Pureza: 98.0%
• Forma y color: Solid
• Peso molecular: 558.650024414063

Atorvastatin acid

CAS: 134523-00-5

The drug is a calcium salt of (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid. It is an oral hypolipidemic agent …

• Fórmula: C₃₃H₃₅FN₂O₅
• Pureza: Min. 98 Area-%
• Forma y color: White Powder
• Peso molecular: 558.64 g/mol

Atorvastatin

CAS: 134523-00-5

Orally active atorvastatin inhibits HMG-CoA reductase, lowers lipids, hinders SV-SMC cell growth, and can up …

• Fórmula: C₃₃H₃₅FN₂O₅
• Pureza: 99.69%
• Forma y color: Solid
• Peso molecular: 558.64

3-Fluoro Atorvastatin Sodium Salt-d5

CAS: 134523-00-5

• Fórmula: C₃₃D₅H₂₉FN₂NaO₅
• Forma y color: Neat
• Peso molecular: 585.652

3-Fluoro Atorvastatin Sodium Salt

CAS: 134523-00-5

Applications 3-Fluoro Atorvastatin Sodium Salt is an impurity of Atorvastatin (A791750, Ca Salt); a selective, …

• Fórmula: C₃₃H₃₄FN₂NaO₅
• Forma y color: Neat
• Peso molecular: 580.62

Des-(N-Phenyl)Carbamoyl Atorvastatin Calcium Salt

CAS: 134523-00-52247346-41-2

• Fórmula: (C₂₆H₂₉FNO₄)•Ca
• Forma y color: Neat
• Peso molecular: 2(438.52) + (40.08)